PropertyValue
?:abstract
  • Severely ill influenza patients are at increased risk of invasive pulmonary aspergillosis (IPA). Previous reports suggest that Coronavirus Disease 2019 (COVID-19) patients may also be at increased risk of IPA. Here we present an Aspergillus co-infection in a COVID-19 immunocompetent patient, complicated by bacteremia and persistent hyperthermia. We describe the challenges in diagnosing IPA in COVID-19 immunocompetent patients and how the patient responded to the treatment.
is ?:annotates of
?:creator
?:doi
?:doi
  • 10.1016/j.mmcr.2020.11.004
?:journal
  • Med_Mycol_Case_Rep
?:license
  • no-cc
?:pdf_json_files
  • document_parses/pdf_json/84e7f387f9bfcc7a15dd297f32cc6da7a5de5334.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7718585.xml.json
?:pmcid
?:pmid
?:pmid
  • 33312851.0
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:sha_id
?:source
  • Elsevier; Medline; PMC
?:title
  • Invasive pulmonary aspergillosis and hyperthermia in an immunocompetent patient with COVID-19
?:type
?:year
  • 2020-12-05

Metadata

Anon_0  
expand all